Voice Analysis for Monitoring Patients With Heart Failure

Description

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.

Conditions

Heart Failure

Study Overview

Study Details

Study overview

This observational study involves ADHF patients at two sites in the United States and Germany. After informed consent and screening assessments, participants will perform daily voice recordings during their hospital stay, from admission until discharge. Alongside voice data, additional clinical information such as left ventricular ejection fraction, NTpro-BNP levels, and ECG-data will be collected for comprehensive analysis. The study's goal is to identify voice-based indicators of heart failure progression, with the potential to enhance remote monitoring and self-management strategies for heart failure patients.

A Pilot Study on AI-Based Voice Analysis for Monitoring Patients Hospitalized With Acute Decompensated Heart Failure

Voice Analysis for Monitoring Patients With Heart Failure

Condition
Heart Failure
Intervention / Treatment

-

Contacts and Locations

Rochester

Mayo Clinic, Rochester, Minnesota, United States, 55902

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Clinically diagnosed with Acutely Decompensated Heart Failure.
  • * At least 18 years of age.
  • * Disabling mental diseases (e.g., Alzheimer's disease)
  • * Clinically diagnosed chronic obstructive pulmonary disease (COPD)
  • * Treatment in ICU or IMU
  • * Dialysis treatment
  • * Previous operations on organs involved in generation of voice (vocal tract, vocal folds, etc.)
  • * Neurodegenerative diseases
  • * Pregnancy
  • * Inability to provide consent

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Noah Labs,

Gerhard Hindricks, MD, PRINCIPAL_INVESTIGATOR, German Heart Institute

Study Record Dates

2024-09